Molecular mimicry, inflammatory bowel disease, and the vaccine safety debate
- PMID: 25238056
- PMCID: PMC4167146
- DOI: 10.1186/s12916-014-0166-6
Molecular mimicry, inflammatory bowel disease, and the vaccine safety debate
Abstract
Preventive immunization has provided one of the major advances in population health during the past century. However, a surprising cultural phenomenon is the emergence of concerns about immunization safety, in part due to prominently controversial biomedical studies. One ongoing theoretical safety concern is the possibility of human molecular mimicry by measles, mumps, rubella (MMR) antigens. The study of Polymeros et al. in this BMC Medicine presents a systematic evaluation and refutation of this safety concern. This provides significant new scientific evidence in support of the safety of pediatric vaccines, which will inform the ongoing policy and cultural understanding of this important public health measure.
Similar articles
-
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12. MMWR Recomm Rep. 2010. PMID: 20448530
-
The MMR question.Lancet. 2000 Jul 8;356(9224):160. doi: 10.1016/S0140-6736(00)02459-4. Lancet. 2000. PMID: 10963263 No abstract available.
-
Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.Vaccine. 2017 May 25;35(23):3116-3122. doi: 10.1016/j.vaccine.2017.04.027. Epub 2017 Apr 28. Vaccine. 2017. PMID: 28457672
-
Is an improved measles-mumps-rubella vaccine necessary or feasible?Crit Rev Immunol. 2003;23(4):323-38. doi: 10.1615/critrevimmunol.v23.i4.40. Crit Rev Immunol. 2003. PMID: 14700273 Review.
-
Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000.Pediatrics. 2001 May;107(5):E84. doi: 10.1542/peds.107.5.e84. Pediatrics. 2001. PMID: 11331734 Review.
Cited by
-
Xenobiotics and loss of tolerance in primary biliary cholangitis.World J Gastroenterol. 2016 Jan 7;22(1):338-48. doi: 10.3748/wjg.v22.i1.338. World J Gastroenterol. 2016. PMID: 26755880 Free PMC article. Review.
-
Unravelling the Oral-Gut Axis: Interconnection Between Periodontitis and Inflammatory Bowel Disease, Current Challenges, and Future Perspective.J Crohns Colitis. 2024 Aug 14;18(8):1319-1341. doi: 10.1093/ecco-jcc/jjae028. J Crohns Colitis. 2024. PMID: 38417137 Free PMC article. Review.
-
Investigating the eukaryotic host-like SLiMs in microbial mimitopes and their potential as novel drug targets for treating autoimmune diseases.Front Microbiol. 2022 Nov 4;13:1039188. doi: 10.3389/fmicb.2022.1039188. eCollection 2022. Front Microbiol. 2022. PMID: 36406429 Free PMC article. No abstract available.
References
-
- Balzola FA, Kahn K, Pera A, Bonino F, Pounder RE, Wakefield AJ. Measles IgM immunoreactivity in patients with inflammatory bowel disease. Ital J Gastroenterol Hepatol. 1998;30:378–382. - PubMed
-
- Wakefield AJ, Murch SH, Anthony A, Malik JLDMCM, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637–641. doi: 10.1016/S0140-6736(97)11096-0. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous